Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Spirocyclic Amine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step route for diazaspiro compounds via CN102267995A. Higher yield, lower cost. Ideal for API intermediates and supply chain optimization.
Novel 4-step route for 4-oxa-7-azaspiro[2.5]octane. High yield, mild conditions. Ideal for LRRK2 inhibitor supply chains.
Patent CN113214255A details a scalable four-step synthesis of 2,6-diazaspiro[3.5]nonane intermediates, offering cost-effective routes for pharmaceutical manufacturing.
Patent CN106883238B reveals a high-yield 4-step route for alpha-azaspiro compounds, offering significant cost reduction and safety improvements for API intermediate manufacturing.